Pilot Test of Contingency Management and Brief Motivational Interviewing + Substance Free Activity Session Interventions + Mindfulness-Based Adherence Promotion
Latest Information Update: 06 Jan 2026
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Acronyms SMART
Most Recent Events
- 05 Dec 2025 Actual primary completion date changed from 31 Jul 2021 to 30 Jul 2021.
- 14 Sep 2021 Status changed from recruiting to completed.
- 16 Nov 2020 Status changed from not yet recruiting to recruiting.